<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, omeprazole and other proton pump inhibitors substantially enhance the antiviral effects of acyclovir in HSV-1- and HSV-2-infected cells. With their known safety profiles, proton pump inhibitors are promising candidates for drug repurposing approaches (
 <xref rid="B15" ref-type="bibr">Ikemura et al., 2017</xref>), in particular for topical preparations.
</p>
